30th Jul 2015 09:41
LONDON (Alliance News) - Tissue Regenix Group PLC Thursday said it has gained further coverage approval for its wound-care product DermaPure under the US national social insurance programme Medicare, getting approval from First Coast Service Options Inc, whose jurisdiction includes Florida, Puerto Rico and US Virgin Islands.
The company said this means DermaPure is now available across 31 states, the US Virgin Islands and Puerto Rico.
"Tissue Regenix continues to make significant progress in securing these critical approvals, not only allowing more patients to benefit from improved clinical outcomes, but demonstrating both the efficacy of the product and the strength of our hybrid commercialisation strategy," said Chief Executive Officer Antony Odell in a statement.
Shares in Tissue Regenix are trading up 5.6% at 20.73 pence Thursday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Tissue Regenix Group